ArticleRheumatology (Oxford, England)2021

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.

Qiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.